Breast Pathway Group – EC x 4 – Accelerated Paclitaxel x 4: Epirubicin & Cyclophosphamide x 4 followed by Accelerated Pa
IJERPH | Free Full-Text | Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer
Paclitaxel and cisplatin with or without cetuximab in metastatic esophageal squamous cell carcinoma: a randomized, multicenter phase II trial - ScienceDirect
Paclitaxel | C47H51NO14 - PubChem
Approved for use in:
MRP-7 Enhances Paclitaxel Resistance and Aggressive Phenotypes of EC... | Download Scientific Diagram
Homoharringtonine demonstrates a cytotoxic effect against triple-negative breast cancer cell lines and acts synergistically with paclitaxel | Scientific Reports
Paclitaxel | Antitumor Agent | MedChemExpress
Use of the Tubulin Bound Paclitaxel Conformation for Structure-Based Rational Drug Design: Chemistry & Biology
Ki-67 response-guided preoperative chemotherapy for HER2-positive breast cancer: results of a randomised Phase 2 study | British Journal of Cancer
Cancers | Free Full-Text | Prognostic Impact of High Baseline Stromal Tumor-Infiltrating Lymphocytes in the Absence of Pathologic Complete Response in Early-Stage Triple-Negative Breast Cancer
JAMA Network Open on Twitter: "RCT: Epirubicin + paclitaxel was non-inferior to the standard epirubicin + cyclophosphamide followed by paclitaxel in patients with operable HRBB2 negative and lymph nodes-positive breast cancer. https://t.co/Z672x44dQL
Paclitaxel | Antitumor Agent | MedChemExpress
Frontiers | Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review
Mechanisms for the transport and accumulation of albumin-bound... | Download Scientific Diagram
Optimising dose-dense regimens for early breast cancer | Cancer World Archive
A novel preventive therapy for paclitaxel-induced cognitive deficits: preclinical evidence from C57BL/6 mice | Translational Psychiatry
Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer | NEJM
